Bethany A. DiPaula

ORCID: 0000-0002-6284-8010
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Schizophrenia research and treatment
  • Opioid Use Disorder Treatment
  • Bipolar Disorder and Treatment
  • Health Sciences Research and Education
  • Substance Abuse Treatment and Outcomes
  • Innovations in Medical Education
  • Mental Health Treatment and Access
  • Tryptophan and brain disorders
  • Pain Management and Opioid Use
  • Patient Safety and Medication Errors
  • Healthcare Decision-Making and Restraints
  • Child and Adolescent Psychosocial and Emotional Development
  • Poisoning and overdose treatments
  • Pharmacovigilance and Adverse Drug Reactions
  • Medication Adherence and Compliance
  • Cardiovascular Syncope and Autonomic Disorders
  • Academic Writing and Publishing
  • Nicotinic Acetylcholine Receptors Study
  • Mobile Health and mHealth Applications
  • Smoking Behavior and Cessation
  • Digital Mental Health Interventions
  • Gambling Behavior and Treatments
  • Alcohol Consumption and Health Effects
  • Mental Health Research Topics

Maryland Department of Health
2024

University of Maryland, Baltimore
2013-2023

National Association of State Mental Health Program Directors
2021

Kaiser Permanente
2021

University of Southern California
2021

North Dakota State University
2021

Howard County Health Department
2015

Baystate Medical Center
2009-2013

Mercy Hospital Springfield
2013

University of Maryland, College Park
2011

Although approximately 20% of adults in the United States experience a mental health condition annually, there continues to be gap provision care because shortage behavioral providers. The National Council for Behavioral Health Medical Director Institute has recommended that number board-certified psychiatric pharmacists (BCPPs), who are clinical with advanced specialized training and treatment patients substance use disorders, expanded help meet this need. BCPPs currently assist expanding...

10.1176/appi.ps.202000066 article EN Psychiatric Services 2021-05-04

Reducing adverse drug reactions (ADRs) is a critical element in providing safe medication use to hospitalized patients. There an abundance of literature describing ADRs and preventable (pADRs) patients; however, little has been published specific psychiatric inpatients. Further knowledge the most common pADRs patients will allow targeted patient safety initiatives be developed.To determine frequent hospital, with emphasis on identifying factors for prevention.Three years at hospital were...

10.1345/aph.1m746 article EN Annals of Pharmacotherapy 2010-04-07

Psychiatric pharmacists have specialized knowledge, skills, and training or substantial experience working with patients psychiatric neurologic disorders. As part of the collaborative team a physician, can provide comprehensive medication management (CMM), direct patient care service, to CMM is standard in which all medications for an individual are assessed determine appropriateness, effectiveness, safety, adherence. Studies shown that when included as medication-related outcomes disorders...

10.9740/mhc.2015.01.001 article EN cc-by-nc Mental Health Clinician 2015-01-01

In the last decade, U.S. opioid overdose crisis has magnified, particularly since introduction of synthetic opioids, including fentanyl. Despite benefits medications for use disorder (MOUD), only about a fifth people with (OUD) in receive MOUD. The ubiquity pharmacists, along their extensive education and training, represents great potential expansion MOUD services, community pharmacies. National Institute on Drug Abuse’s Abuse Treatment Clinical Trials Network (NIDA CTN) convened working...

10.1177/08897077231203849 article EN Substance Abuse 2023-10-01

Varenicline is a novel treatment for smoking cessation; however, the agent has not been well studied in population with severe mental illness. can reportedly cause neuropsychiatric adverse effects, some resulting hospitalizations and/or suicides. We describe case of clinician-observed, worsening psychotic symptoms patient chronic illness who was receiving varenicline. A 45-year-old woman bipolar disorder, mixed type features, admitted to psychiatric hospital due acute decompensation after...

10.1592/phco.29.7.852 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2009-06-26

10.5688/aj7409163 article EN American Journal of Pharmaceutical Education 2010-11-01

To determine if clozapine can be safely utilized in psychiatric patients with benign neutropenia.A single-center, retrospective chart review study of records from 2001 to 2014 was conducted an inpatient hospital. Patients included had neutropenia prior receiving and received using modified monitoring guidelines. All available laboratory values for absolute neutrophil count (ANC) before initiation during treatment were evaluated. The primary endpoint difference ANC after clozapine.A total 26...

10.4088/jcp.15m10315 article EN The Journal of Clinical Psychiatry 2016-10-10

Background: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia. Although serum clozapine levels can help guide treatment, they are underutilized owing to requirements frequent venous blood draws and lack of immediate results. Methods: measured with a novel immunoassay technology (which enables point-of-care development) were compared those by standard liquid chromatography/tandem mass spectrometry (LC-MS/MS). Frozen aliquots 117 samples (N = 48 patients...

10.1097/ftd.0000000000000777 article EN cc-by-nc-nd Therapeutic Drug Monitoring 2020-06-17

Article Abstract Objective: Nonadherence to antidepressants has been reported range widely from 10% 60%. Most adherence studies focus on persistence of use and do not include prescriptions that are picked up by the patient. The objectives this study were determine rate unfilled antidepressant as well identify factors associated with failure fill these prescriptions. Method: This retrospective used administrative pharmacy data a mid-Atlantic managed care organization serving 3.3 million...

10.4088/pcc.10m00998blu article EN The Primary Care Companion For CNS Disorders 2011-01-19

Opioid use disorder is a public health epidemic. There increasing attention being given to opioid abuse and overdose in the United States. The overall of illicit substances by older adults on rise part can be attributed aging Baby Boomers. Furthermore, much prescription drug overdose, but it important note that heroin-related deaths have also increased sharply. Heroin larger substance problem, with more than nine 10 individuals who heroin using at least one other (e.g., cocaine, medication)....

10.3928/00989134-20160314-04 article EN Journal of Gerontological Nursing 2016-04-01

To investigate prescribing patterns for antipsychotic regimens based on intramuscular haloperidol or olanzapine treating acute agitation; to compare the costs of each drug regimen, which included adjunctive anxiolytics and/or anticholinergics; and effectiveness safety regimen.Retrospective medical record review.State psychiatric facility.Twenty-seven patients who received treat 47 episodes agitation 26 38 episodes.Data from receiving between August 2004 March 2007 were reviewed. Mean +/- SD...

10.1592/phco.29.8.930 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2009-07-28

Objective The goal of the present study was to demonstrate that analytical assay interest can detect antipsychotics in human urine specimens. Method Forty inpatients treated with haloperidol, quetiapine, risperidone, or olanzapine were recruited participate a one visit study. During visit, demographic and clinical information collected as well sample forwarded Ameritox Laboratory assayed for presence antipsychotic medications and/or metabolites. Urine samples analyzed determine detection...

10.1002/hup.2482 article EN Human Psychopharmacology Clinical and Experimental 2015-05-25

To assess whether Maryland community pharmacies had Suboxone available for dispensing.This cross-sectional study used a secret shopper model to contact public-facing in Maryland. The shopper, guided by script, asked prescription was the same or next day pick-up. A small convenience sample of who did not have received an in-person visit inquire about medication availability and dispensing barriers.After contacting 99% (n = 1046) pharmacies, confirmed immediate pick-up 31% 326). remaining...

10.1016/j.rcsop.2023.100356 article EN cc-by-nc-nd Exploratory Research in Clinical and Social Pharmacy 2023-11-03

Preceptor development is critical to the success of residency training programs. The American Society Health-System Pharmacists (ASHP), accrediting body for pharmacy programs, identifies qualified preceptors as a “critical factor” in determining program’s compliance with

10.2146/ajhp130312 article EN American Journal of Health-System Pharmacy 2014-03-18
Coming Soon ...